Boehringer outlines next step in $382M expansion

Boehringer Ingelheim has submitted the blueprints for two new buildings on its Connecticut campus, part of its $382 million expansion plan first laid out in 2007. The 60,000 square feet of added space includes a support building for the process development laboratory as well as a new facility for "pilot scale pharmaceutical development equipment and the airlocks associated with these equipment rooms." Report

Suggested Articles

NASH leaders weigh in on the need for a drug for the disease and the challenges in getting it to patients.

The $210 million fund began life by leading a $17 million series A round in Quellis Biosciences.

The nine-story building will house Amgen’s Bay Area employees when it opens early in 2022.